Form 4 for RAPP Rapport Therapeutics, Inc.
Accepted 2026-08-20 16:09:03 ET · period of report 2026-08-19 · accession 0001193125-26-359189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-20 16:09 | 2026-08-19 | RAPP | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $49.90 | -404 | 246.0K | -0.2% | -$20.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | S | D | 404 | $49.90 | 246,022 | D | — | — | (F1) These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025. |